BPA Call W91YTZ23A0014-W91YTZ24F0142
Award Date
7/30/24
Potential Completion Date
8/1/24
Potential Value
$8.3K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Cerilliant Corporation
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fort Meade, MD 20755, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference materials based in Round Rock, Texas. The contract, awarded by the Defense Health Agency (DHA), is for the provision of medical supplies. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type and a ceiling value of $32,348.38. The contract is set to expire on September 30, 2023. Cerilliant Corporation has a history of...
This federal contract is a Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference standards, calibrators, reagents, and laboratory supplies. The $15,562.95 firm fixed-price contract is for the provision of drug reference standards, with a period of performance through June 2025. Cerilliant Corporation holds several significant federal contract Indefinite Delivery...
This federal contract award to Cerilliant Corporation, a foreign-owned manufacturer based in Round Rock, Texas, is for the supply of drug standards used for screening and confirmation testing of urine, blood, and tissue samples from service members suspected of drug use. The $10,010.88 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), a defense agency. Cerilliant, which has over 30 years of experience as a government contractor, will...
This federal contract award to Cerilliant Corporation is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), valued at $15,522.70. The contract is for the provision of drug reference standards and calibration materials to support drug testing and screening of service member specimens, including post-mortem urine, blood, and tissue samples. The contract has a completion date of August 15, 2024 and is a firm fixed price arrangement. Cerilliant Corporation is a global...
This is a BPA (Blanket Purchase Agreement) call awarded by the Defense Health Agency (DHA) to Cerilliant Corporation, a global leader in certified reference materials. The contract, valued at $11,104.95, is for the supply of FTDTL (Forensic Toxicology Drug Testing Laboratory) Cerilliant supplies for the Fort Meade location. This BPA call is part of a larger $250,000 DHA BPA that Cerilliant holds to provide drug reference standards through September 2028. Cerilliant, a foreign-owned, for-profit...
This is a Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Cerilliant Corporation, a global manufacturer of certified reference materials and analytical standards. The contract, valued at $22,803.21, is for the provision of drug screening and confirmation testing services for suspected drug use in service member investigative and/or post-mortem urine, blood, and tissue samples. The contract has an ultimate completion date of September 30, 2025. Cerilliant Corporation, a...
This firm-fixed-price purchase order contract was awarded by the Bureau of Medicine and Surgery (a part of the U.S. Department of Defense) to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference standards based in Round Rock, Texas. The $76,775.55 contract does not have a set-aside designation. Cerilliant has a history of providing essential reference materials and analytical standards to support various government healthcare, research, and...
This firm fixed-price contract award to Cerilliant Corporation, a foreign-owned for-profit manufacturer, is for the provision of drug standards that will be used for screening and testing of service members' specimens. The contract, valued at $12,538.24, was awarded by the Defense Health Agency on March 26, 2024, with a completion date of September 30, 2024. This appears to be a call under a larger Blanket Purchase Agreement (BPA) vehicle, as the contract type is listed as "BPA...
This federal contract award was issued by the Defense Health Agency (DHA) to Cerilliant Corporation, a global leader in certified reference materials. The $17,226.00 Blanket Purchase Agreement (BPA) Call contract is for the supply of FTDTL CERILLIANT SUPPLIES-MEADE, which are drug reference standards used for screening and confirmation testing of service member specimens. Cerilliant, a foreign-owned, for-profit manufacturer, has a strong track record of providing analytical standards and...
Cerilliant Corporation was awarded a $19,723.40 firm fixed price blanket purchase agreement call from the Defense Health Agency to provide drug supplies. As a global leader in certified reference standards for over 30 years, Cerilliant will deliver chemical reference materials from its Round Rock, Texas headquarters to support agency testing and healthcare programs at the place of performance in Fort Meade, Maryland. Cerilliant currently holds several indefinite delivery/indefinite quantity...